Consun Pharmaceutical Group Limited (FRA:C1P)

FRA:C1P Statistics

Total Valuation

FRA:C1P has a market cap or net worth of EUR 1.23 billion. The enterprise value is 848.92 million.

Market Cap	1.23B
Enterprise Value	848.92M

Important Dates

The next estimated earnings date is Friday, August 22, 2025.

Earnings Date	Aug 22, 2025
Ex-Dividend Date	Jun 10, 2025

Share Statistics

Current Share Class	828.84M
Shares Outstanding	n/a
Shares Change (YoY)	+4.12%
Shares Change (QoQ)	+5.23%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	445.04M

Valuation Ratios

The trailing PE ratio is 10.22 and the forward PE ratio is 10.01.

PE Ratio	10.22
Forward PE	10.01
PS Ratio	3.14
PB Ratio	2.12
P/TBV Ratio	2.43
P/FCF Ratio	9.51
P/OCF Ratio	8.56
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.06, with an EV/FCF ratio of 6.56.

EV / Earnings	7.05
EV / Sales	2.47
EV / EBITDA	7.06
EV / EBIT	7.52
EV / FCF	6.56

Financial Position

The company has a current ratio of 3.32, with a Debt / Equity ratio of 0.06.

Current Ratio	3.32
Quick Ratio	3.09
Debt / Equity	0.06
Debt / EBITDA	0.26
Debt / FCF	0.27
Interest Coverage	39.17

Financial Efficiency

Return on equity (ROE) is 22.07% and return on invested capital (ROIC) is 13.41%.

Return on Equity (ROE)	22.07%
Return on Assets (ROA)	10.73%
Return on Invested Capital (ROIC)	13.41%
Return on Capital Employed (ROCE)	21.75%
Revenue Per Employee	124,102
Profits Per Employee	38,079
Employee Count	3,164
Asset Turnover	0.52
Inventory Turnover	2.07

Taxes

In the past 12 months, FRA:C1P has paid 13.59 million in taxes.

Income Tax	13.59M
Effective Tax Rate	10.07%

Stock Price Statistics

The stock price has increased by +204.55% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+204.55%
50-Day Moving Average	1.22
200-Day Moving Average	1.01
Relative Strength Index (RSI)	54.58
Average Volume (20 Days)	1,808

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:C1P had revenue of EUR 392.66 million and earned 120.48 million in profits. Earnings per share was 0.14.

Revenue	392.66M
Gross Profit	296.70M
Operating Income	129.02M
Pretax Income	134.99M
Net Income	120.48M
EBITDA	136.53M
EBIT	129.02M
Earnings Per Share (EPS)	0.14

Balance Sheet

The company has 511.55 million in cash and 35.35 million in debt, giving a net cash position of 476.20 million.

Cash & Cash Equivalents	511.55M
Total Debt	35.35M
Net Cash	476.20M
Net Cash Per Share	n/a
Equity (Book Value)	581.34M
Book Value Per Share	0.65
Working Capital	420.88M

Cash Flow

In the last 12 months, operating cash flow was 143.84 million and capital expenditures -14.42 million, giving a free cash flow of 129.42 million.

Operating Cash Flow	143.84M
Capital Expenditures	-14.42M
Free Cash Flow	129.42M
FCF Per Share	n/a

Margins

Gross margin is 75.56%, with operating and profit margins of 32.86% and 30.68%.

Gross Margin	75.56%
Operating Margin	32.86%
Pretax Margin	34.38%
Profit Margin	30.68%
EBITDA Margin	34.77%
EBIT Margin	32.86%
FCF Margin	32.96%

Dividends & Yields

This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 2.50%.

Dividend Per Share	0.03
Dividend Yield	2.50%
Dividend Growth (YoY)	-68.47%
Years of Dividend Growth	2
Payout Ratio	23.21%
Buyback Yield	-4.12%
Shareholder Yield	-1.59%
Earnings Yield	9.79%
FCF Yield	10.51%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:C1P has an Altman Z-Score of 4.54 and a Piotroski F-Score of 7.

Altman Z-Score	4.54
Piotroski F-Score	7